News - New hospital antibiotic

Profile

News for week ending 19 July 2002

NEW HOSPITAL ANTIBIOTIC

Merck Sharp and Dohme has launched its new hospital antibiotic treatment, INVANZ to the New Zealand market.

INVANZ is for the initial therapy of community-acquired mixed infections (eg.intra-abdominal and skin structure infections).

INVANZ is active against a wide range of common gram-positive and gram-negative aerobic and anaerobic bacterial pathogens.

Applications are being made to have the drug included onto New Zealand formularies around the country.

CONTINUING EDUCATION
Complete this month's questionnaire to qualify for extra Continuing Education credits. Click here For the answers to last month's quiz click here.
PHARMACY AWARDS
Click here to find out who the winners are for the Pharmacy Today/Zuellig Pharma Pharmacy Awards 2002. Also view and purchase photos of the Awards.
THIS ISSUE
For the leading stories in our latest issue of Pharmacy Today magazine visit our welcome page.
SUBSCRIPTIONS
To subscribe to Pharmacy Today, or to purchase The Beauty Manual or The Pharmacy Healthcare Handbook click here.
CLASSIFIED ADVERTS
Job vacancies, items for sale, business opportunities and more. Updated weekly. click here.

Consumer Health Information

New Zealand Doctor Online